uniQure (QURE) Interest Coverage Ratio (2016 - 2026)
uniQure (QURE) recorded quarterly Interest Coverage Ratio of 3.26 in Q1 2026, down 156.3% quarter-over-quarter from 5.79 in Q4 2025, and down 25.18% on a YoY basis from 4.35 in Q1 2025.
uniQure (QURE) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
uniQure's Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 3.26 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 25.18% year-over-year to 3.26; the TTM figure through Mar 2026 stood at 0.92 (up 65.78% YoY), while the FY2025 annual figure was 0.8, up 72.17% from the prior year.
- Interest Coverage Ratio was 3.26 for Q1 2026 at uniQure, down from 5.79 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 9.04 in Q4 2023 to a low of 21.5 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 5.77 across 5 years, with a median of 3.08 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 134.08% in 2024, then jumped 287.88% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 7.74 in 2022, then grew by 16.84% to 9.04 in 2023, then sank by 134.08% to 3.08 in 2024, then surged by 287.88% to 5.79 in 2025, then sank by 156.3% to 3.26 in 2026.
- The last three Interest Coverage Ratio figures came in at 3.26 (Q1 2026), 5.79 (Q4 2025), and 3.05 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -3.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.26 |
| Dec 31, 2025 | 5.79 |
| Sep 30, 2025 | -3.05 |
| Jun 30, 2025 | -2.81 |
| Mar 31, 2025 | -2.60 |
| Dec 31, 2024 | -3.08 |
| Sep 30, 2024 | -2.42 |
| Jun 30, 2024 | -2.72 |
| Mar 31, 2024 | -3.37 |
| Dec 31, 2023 | 9.04 |
| Sep 30, 2023 | -5.30 |
| Jun 30, 2023 | -9.51 |
| Mar 31, 2023 | -20.82 |
| Dec 31, 2022 | 7.74 |
| Sep 30, 2022 | -19.39 |
| Jun 30, 2022 | -20.81 |
| Mar 31, 2022 | -21.50 |
| Dec 31, 2021 | -107.46 |
| Sep 30, 2021 | -23.39 |
| Jun 30, 2021 | 209.26 |